Copyright: ©Author(s) 2026.
World J Hepatol. Mar 27, 2026; 18(3): 115411
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.115411
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.115411
Figure 1
Preferred Reporting Items for Systematic Reviews and Meta-Analyses chart of included studies.
- Citation: Alam U, Rath S, Ansab M, Kashif A, Sethi FA, Siddiqui HT, Afridi ZAK, Burhan M, Ali MA, Moiz A, Bacha Z, Khan A, Ahmed R, Alatise MB, Kamil KA. Efruxifermin in patients with metabolic dysfunction-associated steatohepatitis: A GRADE-assessed systematic review and meta-analysis. World J Hepatol 2026; 18(3): 115411
- URL: https://www.wjgnet.com/1948-5182/full/v18/i3/115411.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i3.115411